Connaissances sur le dépistage et le cancer du col de l’utérus à la Réunion : application d’une classification ascendante hiérarchique

Touzani, Rajae; Bendiane, Marc-Karim; Bouhnik, Anne-Déborah; Bruneau, L.; Mancini, J.; Chirpaz, Emmanuel; Huiart, Laëtitia

doi:10.1016/j.respe.2018.03.320

Cited by 2 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Since 2009, as part of the Organized Cervical Cancer Screening (OCCS) program, an invitation is sent out by post to women who have not undergone CC screening in the past 3 years [6]. The participation rate of women who receive such invitations remains low (23-24%) [7]. A 2017 survey of a representative sample of 1000 women showed the main determinants of non-adherence to OCCS to be lower socioeconomic status, a lack of knowledge about CC screening, low literacy rates, and immigration from other Indian Ocean territories [7].…”

Section: Introductionmentioning

confidence: 99%

“…The participation rate of women who receive such invitations remains low (23-24%) [7]. A 2017 survey of a representative sample of 1000 women showed the main determinants of non-adherence to OCCS to be lower socioeconomic status, a lack of knowledge about CC screening, low literacy rates, and immigration from other Indian Ocean territories [7].…”

Section: Introductionmentioning

confidence: 99%

“…However, if vaginal self-sampling (VSS) has been suggested as an alternative to cliniciancollected cervical sampling for HPV testing, in unscreened or under-screened women, it has not turned into clinical practice yet. A good proportion of women (63%) interviewed in the 2017 survey were nonetheless in favour of home-based self-sampling (HBSS) CC screening [7].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Assessing the Acceptability of Home-Based HPV Self-Sampling: A Qualitative Study on Cervical Cancer Screening Conducted in Reunion Island Prior to the RESISTE Trial

Pourette

Cripps

Guerrien

et al. 2022

Cancers

View full text Add to dashboard Cite

Cervical cancer incidence and mortality rates are 2 to 3 times higher in the overseas department of Reunion compared with mainland France. RESISTE’s cluster-randomized controlled trial aims to test the effectiveness of home-based self-sampling (HBSS) through a high-risk oncogenic papillomavirus test sent out by post to women who have not been screened in the past 3 years, despite having been invited to do so through a reminder letter. Prior to the trial, qualitative research was carried out to understand screening barriers and assess anticipated acceptability. Semi-structured interviews were conducted with 35 women and 20 healthcare providers. Providers consider HBSS a viable method in reaching women who tend not to visit a doctor regularly, or who are reluctant to undergo a smear pap, as well as those who are geographically isolated. They considered, however, that women would require support, and that outreach was necessary to ensure more socially isolated women participate. The majority of the women surveyed were in favour of HBSS. However, two-thirds voiced concerns regarding the test’s efficiency and their ability to perform the test correctly, without harming themselves. Based on these findings, recommendations were formulated to reassure women on usage and quality, and to help reach socially isolated women.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Assessing the Acceptability of Home-Based HPV Self-Sampling: A Qualitative Study on Cervical Cancer Screening Conducted in Reunion Island Prior to the RESISTE Trial

Pourette

Cripps

Guerrien

et al. 2022

Cancers

View full text Add to dashboard Cite

show abstract

“I would never have gone for screening if it hadn't arrived, this home kit”. Motivation, Capacity and Opportunities for Cervical Cancer Home-based Vaginal Self-sampling in Reunion Island: a qualitative study

POURETTE,

CRIPPS,

HASSINE

et al. 2024

Preprint

View full text Add to dashboard Cite

Background: In 2022, RESISTE conducted a cluster-randomised trial to assess the feasibility and effectiveness of home delivery of HPV vaginal self-sampling kits. The trial targeted women living in deprived areas who were not up to date with their screening. This article presents the results of the post-intervention qualitative study conducted in Reunion Island. The study explores women's motivation and capacity to conduct home-based vaginal self-sampling and analyses the influence of providing a financial incentive (voucher upon return) and of returning the kit by post or to a health professional. Method: A total of 35 semi-structured interviews were conducted with women respondents who returned the kit (16), non-respondents (13) and health professionals contacted by women during the trial (6). Results: After receiving the kit, several women underwent screening either by self-sampling or by visiting a health professional. Ease of use, convenience and privacy were key factors in self-sampling uptake. Receiving the kit at home creates a sense of being targeted which reinforces the perceived relevance of screening and further encourages uptake. Relatives generally had a facilitating effect, encouraging self-sampling and follow-up. Amongst women respondents, a HPV positive result, was a strong motivator to undergo a follow-up smear test. Nevertheless, a lack of prior knowledge of vaginal self-sampling, led to a lack of trust in the programme amongst women sometimes likened by women to a scam. This and the perceived complexity of the procedure were the main demotivating factors. The financial incentive did not reverse this trend. On the contrary, it contributed to doubts regarding authenticity. In addition, the health professionals contacted rarely encouraged women to self-sample. Conclusions: Women appreciated receiving an HPV vaginal self-sampling kit at home. Motivation and capacity could however be improved by increasing prior communication – to both women and health professionals - on self-sampling in general, and more specifically on reliability, sample preservation and ease of use. User-friendliness could also be improved by providing HPV tests results more quickly. Providing the option of collecting and returning the kit to a health professional of women’s choice helps ensure they receive adapted information and support. Trial Registration: 6 February 2020 - "Sud-Ouest et Outre-Mer II" ethics committee - Version 04 dated 29 July 2023 is currently in force - ID-RCB no.: 2020-A0002237 (File 2-20-006 id6698) 2°HPs.

show abstract

Connaissances sur le dépistage et le cancer du col de l’utérus à la Réunion : application d’une classification ascendante hiérarchique

Cited by 2 publications

References 0 publications

Assessing the Acceptability of Home-Based HPV Self-Sampling: A Qualitative Study on Cervical Cancer Screening Conducted in Reunion Island Prior to the RESISTE Trial

Assessing the Acceptability of Home-Based HPV Self-Sampling: A Qualitative Study on Cervical Cancer Screening Conducted in Reunion Island Prior to the RESISTE Trial

“I would never have gone for screening if it hadn't arrived, this home kit”. Motivation, Capacity and Opportunities for Cervical Cancer Home-based Vaginal Self-sampling in Reunion Island: a qualitative study

Contact Info

Product

Resources

About